US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

First Trust Nasdaq Pharmaceuticals ETF

41.27

+0.82002.03%

Post-market: 41.270.00000.00%18:39 EDT

Volume:1.26M

Turnover:52.12M

Market Cap:1.06B

PE:- -

High:41.37

Open:40.60

Low:40.60

Close:40.45

52wk High:43.52

52wk Low:28.77

Shares:25.80M

Float Shares:25.80M

Volume Ratio:15.04

T/O Rate:4.90%

Dividend:0.29

Dividend Rate:0.71%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Will Drug Approvals Change Merck (MRK) Narrative

Simply Wall St.

Bristol Myers Squibb (BMY) Expands CAMZYOS Approval, Is The Stock Still A Bargain?

Simply Wall St.

Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors

Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day

AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says

MT Newswires Live

SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market

Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone

Smaio - Signs Sales Agency Agreement with Depuy Synthes for US Market

THOMSON REUTERS

General Medicine Raises $120 Mln to Build the Healthcare Store

Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says

MT Newswires Live

General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company

THOMSON REUTERS

European Shares Gain as Genmab Jumps, Bond Yields Retreat

LIVE Markets-a Health Boost for the STOXX

Genmab at 3-Year High After Blood Cancer Drug Combination Study Results

Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR

L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports

Medtronic PLC Stock Outperforms Competitors on Strong Trading Day

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Bristol-Myers Squibb Co: Prelim Total Acquired Iprd and Licensing Income $1,536 Mln for Three Months Ended September 30, 2026

THOMSON REUTERS

AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/FTXH/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTXH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","market":"US","secType":"STK","nameCN":"First Trust Nasdaq Pharmaceuticals ETF","latestPrice":41.27,"timestamp":1791576000000,"preClose":40.45,"halted":0,"volume":1263440,"hourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"delay":0,"changeRate":0.020271940667490735,"floatShares":25800002,"shares":25800002,"eps":0,"marketStatus":"Market Closed","change":0.82,"latestTime":"10-09 16:00:00 EDT","open":40.6,"high":41.37,"low":40.6,"amount":52122476.824159995,"amplitude":0.019036,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":40.45,"sharesOutstanding":850002,"nav":40.46,"aum":1045891080.92,"dividendRate":0.007056,"bidAskSpread":0.001796,"preHourTrading":{"tag":"盘前","latestPrice":40.45,"preClose":40.45,"latestTime":"07:38 EDT","volume":1,"amount":40.45,"timestamp":1791545911139,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":41.27,"preClose":41.27,"latestTime":"18:39 EDT","volume":685055,"amount":28272142.39,"timestamp":1791585556641,"change":0,"changeRate":0,"amplitude":0.003392},"volumeRatio":15.04134634604464,"impliedVol":0.216,"impliedVolPercentile":0.996},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTXH\",,,,,undefined,":{"symbol":"FTXH","floatShares":25800002,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":15.04134634604464,"shares":25800002,"dividePrice":0.2912,"high":41.37,"amplitude":0.019036,"preClose":40.45,"low":40.6,"week52Low":28.77,"pbRate":"--","week52High":43.52,"institutionHeld":0,"latestPrice":41.27,"eps":0,"divideRate":0.007056,"volume":1263440,"delay":0,"ttmEps":0,"open":40.6,"prevYearClose":32.9401,"prevWeekClose":40.73,"prevMonthClose":41.47,"prevQuarterClose":41.47,"fiveDayClose":40.73,"twentyDayClose":40.4666,"sixtyDayClose":38.5244},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTXH\",params:#limit:5,,,undefined,":[{"date":"2026-09-24","symbol":"FTXH","amount":0.0113,"announcedDate":"2026-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-24","defaultRemindTime":1790256600000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-30","payableDate":"2026-09-24","currency":"USD","dateTimestamp":1790222400000,"payDate":"2026-09-30"},{"date":"2026-06-25","symbol":"FTXH","amount":0.092,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-25","defaultRemindTime":1782394200000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-25","currency":"USD","dateTimestamp":1782360000000,"payDate":"2026-06-30"},{"date":"2026-03-26","symbol":"FTXH","amount":0.0573,"announcedDate":"2026-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-26","defaultRemindTime":1774531800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-26","currency":"USD","dateTimestamp":1774497600000,"payDate":"2026-03-31"},{"date":"2025-12-12","symbol":"FTXH","amount":0.1294,"announcedDate":"2025-12-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-12","defaultRemindTime":1765549800000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-12","currency":"USD","dateTimestamp":1765515600000,"payDate":"2025-12-31"},{"date":"2025-09-25","symbol":"FTXH","amount":0.1453,"announcedDate":"2025-09-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-25","defaultRemindTime":1758807000000,"name":"First Trust Nasdaq Pharmaceuticals ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-25","currency":"USD","dateTimestamp":1758772800000,"payDate":"2025-09-30"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTXH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0056,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-30","value":0.0286,"currency":"USD"},{"executeDate":"2017-03-23","recordDate":"2017-03-27","paymentDate":"2017-03-31","value":0.0313,"currency":"USD"},{"executeDate":"2017-06-22","recordDate":"2017-06-26","paymentDate":"2017-06-30","value":0.0553,"currency":"USD"},{"executeDate":"2017-09-21","recordDate":"2017-09-22","paymentDate":"2017-09-29","value":0.3448,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTXH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTXH\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673699730","title":"Will Drug Approvals Change Merck (MRK) Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2673699730","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673699730?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:25","pubTimestamp":1791325537,"startTime":"0","endTime":"0","summary":"Recent Merck news spans multiple therapeutic areas, including an FDA approval for WELIREG plus LENVIMA in advanced renal cell carcinoma, an FDA label update for WINREVAIR in pulmonary arterial hypertension, and positive Phase 2b/3 BRUNELLO data in diabetic macular edema, alongside collaboration progress, licensing activity and a withdrawn oncology filing.\nThe mix of a new dual cancer regimen, a strengthened PAH label, advancing retinal assets and a large KRAS G12D licensing deal highlights...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/288502-card/1788951998716","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/288502-card/1788951998716"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/will-drug-approvals-change-merck-mrk-narrative","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-mrk/merck/news/will-drug-approvals-change-merck-mrk-narrative","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0942090050.USD","LU1989771016.USD","LU0511384066.AUD","LU1989772840.SGD","LU2468319806.SGD","LU0965509101.SGD","BK4585","LU1934455277.USD","LU0320765646.SGD","BK4588","LU0072461881.USD","SG9999002224.SGD","IE00BJJMRZ35.SGD","LU1941712264.USD","LU0965508806.USD","GDOC","LU1941712348.USD","LU2361044865.SGD","LU1023059063.AUD","SG9999014567.USD","SG9999013999.USD","LU2433249047.HKD","LU1699723380.USD","LU0070302665.USD","IE00BLSP4452.SGD","LU2491050154.USD","IE0002141913.USD","JDOC","LU1061106388.HKD","IXJ","LU0965509010.AUD","LU2456880835.USD","SG9999015341.SGD","SG9999014559.SGD","LU2106854487.HKD","PPH","LU2023250504.SGD","LU1929549753.HKD","VHT","LU1923622614.USD","LU0859254822.USD","SG9999002232.USD","BK4550","IE0009355771.USD","LU0861579265.USD","FHLC","LU0124676726.USD","LU0289961442.SGD","BK4559","LU1974910355.USD","LU0057025933.USD","SGXZ57979304.SGD","LU0203347892.USD","LU0320765489.SGD","LU2125154935.USD","LU1066051498.USD","LU0058720904.USD","MRK","XLV","LU2360032135.SGD","HRTS","SG9999014542.SGD","LU2125154778.USD","LU2324357040.USD","LU2125909247.SGD","LU0823416689.USD","LU1035773651.USD","LU1032466523.USD","LU0203345920.USD","LU0965509283.SGD","RXL","SG9999001176.USD","SG9999001440.SGD","IE00BLSP4239.USD","LU0266013472.USD","BMED","LU1116320737.USD","LU0689626769.HKD","LU2461242641.AUD","IE00BSNM7G36.USD","LU1066053197.SGD","LU0098860793.USD","SG9999014575.USD","LU1934455863.HKD","LU0234572021.USD","LU2361044949.HKD","LU0006306889.USD","LU2089984988.USD","BK4534","LU1057294990.SGD","IE00BN8TJ469.HKD","LU2125909593.SGD","LU2491050071.SGD","LU0162691827.USD","LU2357627491.SGD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1162221912.USD","IHE","LU1571399168.USD","SG9999001176.SGD","LU0106261372.USD","LU2417539215.USD","TRUH","IE000M9KFDE8.USD","LU0868494617.USD","LU0289739343.SGD","LU1066051225.USD","LU2491049909.HKD","LU0208291251.USD","LU1116320901.HKD","LU1066051811.HKD","LU1201861249.SGD","IE00BJT1NW94.SGD","LU0477156953.USD","LU2112291526.USD","LU2361045086.USD","LU0265550359.USD","IE00BBT3K403.USD","LU0238689110.USD","LU1069347547.HKD","IYH","LU0122379950.USD","IE00B2B36J28.USD","LU1989772923.USD","FTXH","LU1093756168.USD","BK4533","LU0985320562.USD","LU0130102774.USD","LU1291159041.SGD","BK4516","LU0472753341.HKD","LU0432979614.USD","BK4007","LU1037948541.HKD","LU0868494708.USD","SG9999015358.SGD","LU1585245621.USD","LU0211331839.USD","LU0265550946.USD","LU2023250843.SGD","LU1037948897.HKD","LU0648001328.SGD","LU1934455194.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","PAWZ","LU0289739699.SGD","LU0069063385.USD","LU1983299246.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU0130517989.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673163069","title":"Bristol Myers Squibb (BMY) Expands CAMZYOS Approval, Is The Stock Still A Bargain?","url":"https://stock-news.laohu8.com/highlight/detail?id=2673163069","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673163069?lang=en_us&edition=fundamental","pubTime":"2026-10-07 06:19","pubTimestamp":1791325173,"startTime":"0","endTime":"0","summary":"Bristol-Myers Squibb (BMY) just received expanded FDA approval for CAMZYOS in symptomatic obstructive hypertrophic cardiomyopathy, now including eligible pediatric patients. This development sharpens the focus on how this cardiac franchise feeds into the broader equity story.\nCAMZYOS’ broader label arrives after a mixed stretch for Bristol-Myers Squibb’s stock, with a 1-day share price return of 1.33% following the news, a 7-day share price decline of 5.20%, and a 30-day share price drop of...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/25798-card/1789118977455","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/company-cover/25798-card/1789118977455"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb/news/bristol-myers-squibb-bmy-expands-camzyos-approval-is-the-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-bmy/bristol-myers-squibb/news/bristol-myers-squibb-bmy-expands-camzyos-approval-is-the-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0321505439.SGD","LU1074936037.SGD","LU0225771236.USD","IE0002141913.USD","LU0321505868.SGD","LU1868836591.USD","BK4559","LU1883839398.USD","LU0306807586.USD","BK4585","IHE","LU1323610961.USD","IE00B2B36J28.USD","LU0882574055.USD","LU1718418525.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU2125154935.USD","LU0061475181.USD","LU0306806265.USD","LU1585245621.USD","LU1868837300.USD","LU1291159041.SGD","LU1093756168.USD","LU1261432733.SGD","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU2596442595.SGD","LU1670710588.SGD","BMY","LU1670710661.SGD","LU2360032135.SGD","LU0432979614.USD","LU0096364046.USD","IE00BFXG1179.USD","LU0237698245.USD","LU1571399168.USD","LU1236620750.USD","LU1670711040.USD","BK4532","LU2125154778.USD","IE00BJT1NW94.SGD","LU0985481810.HKD","FTXH","LU1236620834.HKD","LU2242646821.SGD","LU0114720955.EUR","LU1093756325.SGD","LU0225284248.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673066872","title":"Perrigo Co. PLC Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2673066872","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673066872?lang=en_us&edition=fundamental","pubTime":"2026-10-07 05:29","pubTimestamp":1791322140,"startTime":"0","endTime":"0","summary":"DJ Perrigo Co. PLC Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Perrigo Co. PLC  slid 3.05% to $14.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,818.93 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.The stock's fall snapped a two-day winning streak.Perrigo Co. PLC closed 37.71% short of its 52-week high of $22.48, which the company achieved on October 6th.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 0.73% to $254.78, Procter & Gamble Co.  rose 1.69% to $148.41, and Abbott Laboratories  fell 1.94% to $98.16.Trading volume  remained 821,454 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RXL","XLP","FSTA","JNJ","BK4559","LU1721429402.USD","UGE","IE000F7OJYX1.SGD","LU1066051498.USD","IE00BKVL7J92.USD","BMED","ABT","LU2129689514.USD","XLV","LU0994945656.USD","GB00BDT5M118.USD","LU1244550221.USD","MEDX","LU0683600562.USD","IE00B4R5TH58.HKD","IHI","FTXH","IE00B19Z3581.USD","IYH","VHT","GDOC","PG","IHE","LU1674673691.USD","IE00BJJMRZ35.SGD","LU1057294990.SGD","LU1551013425.SGD","LU1043141123.HKD","IE00BWXC8680.SGD","LU0070302665.USD","LU2023250330.USD","PJP","TMED","TRUH","JDOC","IE0001KFT4U8.USD","TRUO","LU2471134796.USD","FHLC","LU0345770993.USD","LU1721429741.USD","IXJ","LU1868837300.USD","LU2089984988.USD","PRGO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673606535","title":"Bristol Myers Squibb Co. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673606535","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673606535?lang=en_us&edition=fundamental","pubTime":"2026-10-07 04:37","pubTimestamp":1791319020,"startTime":"0","endTime":"0","summary":"DJ Bristol Myers Squibb Co. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Bristol Myers Squibb Co.  rallied 1.33% to $59.59 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.58% to 7,818.93 and the Dow Jones Industrial Average  rising 0.49% to 51,521.28.The stock's rise snapped a five-day losing streak.Bristol Myers Squibb Co. closed 13.18% short of its 52-week high of $68.64, which the company achieved on August 19th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 0.73% to $254.78, Pfizer Inc.  rose 0.33% to $27.50, and Abbott Laboratories  fell 1.94% to $98.16.Trading volume  remained 1.6 million below its 50-day average volume of 11.5 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 6, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009355771.USD","FTXH","IE00BFXG1179.USD","LU1983299246.USD","LU0061475181.USD","LU1670710588.SGD","LU1032466523.USD","LU0432979614.USD","LU1585245621.USD","LU1868836914.USD","LU1093756168.USD","IE00BFTCPJ56.SGD","LU2125154935.USD","BK4588","LU0114720955.EUR","IE0002141913.USD","LU1323610961.USD","IE00B2B36J28.USD","LU0321505868.SGD","LU1093756325.SGD","LU1989771016.USD","LU2242646821.SGD","LU1236620834.HKD","LU0306806265.USD","LU1868836591.USD","LU1883839398.USD","LU2242652126.USD","LU1291159041.SGD","BK4559","LU0306807586.USD","LU0237698245.USD","LU0882574055.USD","LU1261432733.SGD","LU1074936037.SGD","LU1670711123.USD","LU1430594728.SGD","LU2596442595.SGD","LU2360032135.SGD","BK4585","LU2125154778.USD","LU0267386448.USD","LU1868837300.USD","IE00BJT1NW94.SGD","BK4532","LU1670710661.SGD","IHE","LU1236620750.USD","LU0985481810.HKD","LU0321505439.SGD","LU0456855351.SGD","LU1718418525.SGD","LU2133065610.SGD","IE00BSNM7G36.USD","LU1868837136.USD","LU1571399168.USD","LU0096364046.USD","BK4007","IE00BJJMRZ35.SGD","LU0225771236.USD","BK4534","LU0225284248.USD","LU0868494617.USD","BK4581","LU1868836757.USD","BMY","LU1670711040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050342","title":"AbbVie's Epkinly Could Be Preferred Frontline DLBCL Agent, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050342?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:41","pubTimestamp":1791304881,"startTime":"0","endTime":"0","summary":"AbbVie's  Epkinly could become a preferred frontline option in diffuse large B-cell lymphoma, as its phase 3 result looks favorable against other recently positive regimens on a cross-trial basis, UBS Securities said.The investment firm said in a Monday note that the data would support use of Epkinly with R-CHOP chemotherapy, potentially ahead of combinations such as Roche's Polivy and glofitimab.UBS sees a potential multi-billion-dollar opportunity, versus consensus peak sales of just $1 billion to $2 billion for AbbVie, which splits economics with Genmab.The brokerage also noted the study succeeded in a broader patient population than expected, and said it still needs to see full data and safety, which could come at ASH in December.UBS has a neutral rating on AbbVie, with a $260 price target.Price: 267.95, Change: +2.19, Percent Change: +0.83","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PJP","LU0256863811.USD","LU0114720955.EUR","BK4581","LU0310799852.SGD","RXL","IE0002141913.USD","LU1496350171.SGD","VHT","LU1718418525.SGD","IXJ","ABBV","LU2237443382.USD","LU1074936037.SGD","TRUH","MEDX","LU0211328371.USD","SG9999015978.USD","SG9999011175.SGD","LU0726765562.USD","LU2089984988.USD","IYH","GLAM","LU1061106388.HKD","LU0689626769.HKD","IE0002270589.USD","FHLC","LU1934455277.USD","LU0456855351.SGD","IE00B3PB1722.GBP","LU2237443895.HKD","LU2433249047.HKD","LU2237443465.HKD","LU0472753341.HKD","IE00BDGV0183.EUR","LU1551013425.SGD","LU1923622614.USD","FTXH","XLV","LU0198837287.USD","LU0289739699.SGD","LU1267930573.SGD","LU0069063385.USD","PPH","LU0234572021.USD","SG9999015945.SGD","JDOC","LU0203345920.USD","AGNG","LU0029864427.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673050845","title":"SMAIO Signs Sales Agency Agreement with DePuy Synthes for US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673050845","media":"Reuters","labels":["corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673050845?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:34","pubTimestamp":1791304473,"startTime":"0","endTime":"0","summary":"BRIEF-SMAIO Signs Sales Agency Agreement With DePuy Synthes For US MarketOct 6 (Reuters)-SMAIO SAALSMA.PA:SMAIO - SIGNS SALES AGENCY AGREEMENT WITH DEPUY SYNTHES FOR US MARKETSource text:ID:nBw7kzLQvaFurther company coverage:ALSMA.PA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","LU2468319806.SGD","RXL","LU0124676726.USD","JDOC","FHLC","LU1228905037.USD","IHE","LU1732799900.SGD","FTXH","PJP","GDOC","IE000F7OJYX1.SGD","LU1196500208.SGD","IE00B4R5TH58.HKD","IE00BFXG1179.USD","IYH","IE0000B7K699.USD","IE00BN8TJ469.HKD","LU1074936037.SGD","LU0820561909.HKD","IE00B3T34201.USD","BK4550","JNJ","LU1221951129.SGD","LU2129689514.USD","LU2430703095.HKD","VHT","XLV","IE00BVYPNV92.GBP","LU2403377893.USD","LU0320765646.SGD","LU1585245621.USD","LU0689626769.HKD","BK4568","BK4592","LU0345769631.USD","IE00BGHQF631.EUR","BK4533","LU0098860793.USD","LU0289739699.SGD","LU1551013342.USD","BMED","LU1935042991.SGD","LU0545039389.USD","TRUH","LU0466842654.USD","SG9999013999.USD","IXJ","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673503540","title":"Lilly’s New Basal Insulin Candidate Clears Key Early Trial Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2673503540","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673503540?lang=en_us&edition=fundamental","pubTime":"2026-10-07 00:30","pubTimestamp":1791304237,"startTime":"0","endTime":"0","summary":"Eli Lilly And Company ($LLY) announced an update on their ongoing clinical study. Eli Lilly and Company (LLY) has completed a Phase 1 trial titled ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lillys-new-basal-insulin-candidate-clears-key-early-trial-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lillys-new-basal-insulin-candidate-clears-key-early-trial-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU0787776722.HKD","SG9999018865.SGD","ILDR","BK4516","BK4599","ELIS","LU1983299246.USD","LU2237443622.USD","SGXZ81514606.USD","LU2462157665.USD","LU2168564149.EUR","LU2089284900.SGD","LU2168564065.EUR","LU1623119135.USD","LU2023250330.USD","SG9999015952.SGD","IE00B1XK9C88.USD","LU1720051017.SGD","LU0256863902.USD","LU2750360641.GBP","SGXZ31699556.SGD","PJP","MEDX","LU0823416689.USD","LU0109391861.USD","SG9999017495.SGD","LU1712237335.SGD","LU0006306889.USD","GB00BDT5M118.USD","LU0174119429.USD","LU1291159041.SGD","SG9999013999.USD","LU0786609619.USD","LU2471134879.HKD","LU1232071149.USD","LU1868837300.USD","SG9999014906.USD","THNR","LU0354030511.USD","AGNG","IE00B775H168.HKD","LU2471134523.USD","LU2471134796.USD","LU2063271972.USD","LU0708995401.HKD","IE00BFSS8Q28.SGD","LU2106854487.HKD","LU2491049909.HKD","SG9999014880.SGD","LU2324357040.USD","LU2746668461.USD","LU1551013425.SGD","LU0198837287.USD","LU0061475181.USD","IE00B4JS1V06.HKD","LU1366192091.USD","IE00BK4W5M84.HKD","IE0004445015.USD","IE00BKDWB100.SGD","LU0432979614.USD","LU1974910355.USD","LU0097036916.USD","LU2361045086.USD","LU2111349929.HKD","LU2211815571.USD","SG9999015978.USD","IE00BFSS7M15.SGD","LU0203202063.USD","LU2089283258.USD","LU0683600562.USD","LU0820561909.HKD","LU0320765059.SGD","LU1323610961.USD","LU1093756325.SGD","SGXZ57979304.SGD","OZEM","LU2552382215.SGD","LU0820562030.AUD","HRTS","LLYX","LU1548497426.USD","LU0158827781.USD","LU0210536198.USD","LU0079474960.USD","LLII","LU0385154629.USD","IE00BJJMRY28.SGD","CURE","LU1551013342.USD","CANC","LU0466842654.USD","LU1061106388.HKD","LU2357305700.SGD","IHE","LU0417517546.SGD","LU2746668974.SGD","LU0234572021.USD","LU0456855351.SGD","SG9999014898.SGD","LU2360106947.USD","LU0889565916.HKD","LU1280957306.USD","LLY","LU1804176565.USD","IE00BJJMRZ35.SGD","IE0001KFT4U8.USD","BK4534","LU1145028129.USD","LU0823434583.USD","LU1023059063.AUD","LU1868836757.USD","LU0289739699.SGD","LU0345770308.USD","LU0820561818.USD","LU1720051108.HKD","LU1127390331.HKD","LU2417539215.USD","LU2552382132.HKD","LU2750360997.AUD","XLV","LU0225283273.USD","MEDI","TMED","IE00BFTCPJ56.SGD","LU0943347566.SGD","SG9999015945.SGD","LU2087625088.SGD","BK4588","IE00BK4W5L77.USD","LU0114720955.EUR","LU1035775433.USD","LU2756315664.SGD","LU1267930730.SGD","LU2552382058.USD","LU1814569148.SGD","LU2023250504.SGD","IE00BJJMRX11.SGD","LU2471134952.CNY","LU0471298777.SGD","LU1868836591.USD","LU2236285917.USD","VHT","LU0094547139.USD","LU1691799644.USD","IE00B4R5TH58.HKD","LU0203201768.USD","LU0238689110.USD","BK4533","LU1917777945.USD","LU0256863811.USD","MHIP","LU2361044949.HKD","LU2237438978.USD","LU2462591350.SGD","SGXZ99366536.SGD","IE00B7KXQ091.USD","LU2089984988.USD","LU2264538146.SGD","LU2491050154.USD","LU1069344957.HKD","JDOC","LU2602419157.SGD","LU2108987350.USD","SG9999001176.USD","LU2112291526.USD","LU1988902786.USD","BK4007","LU2237443382.USD","LU2271345857.HKD","IE00BKPKM429.USD","SG9999015986.USD","IYH","FTXH","LU1629891620.HKD","LU2028103732.USD","LU0058720904.USD","LU2213496289.HKD","LU0158827948.USD","LU0640476718.USD","LU1868836914.USD","LU2237443895.HKD","LU2265009873.SGD","LU1093756168.USD","LU2756315318.SGD","LU0323591593.USD","LU2168564222.USD","IE00BN29S564.USD","WDNA","FHLC","IE0002141913.USD","LU0882574139.USD","SG9999018857.SGD","SG9999014914.USD","IE00B2B36J28.USD","LU2237443465.HKD","LU0354030438.USD","LU0672654240.SGD","LU2168564495.EUR","LLYZ","LU1989771016.USD","IXJ","LU0689472784.USD","IE00BWXC8680.SGD","LU0106261372.USD","IE0004445239.USD","LU0823434740.USD","SGXZ51526630.SGD","LU0964807845.USD","LU2468319806.SGD","LU2896262040.SGD","PPH","LU2491050071.SGD","LU0109394709.USD","LU0882574055.USD","TRUH","LU2456880835.USD","LU2237443549.SGD","LU0133085943.USD","BK4585","IE00B1BXHZ80.USD","LU1057294990.SGD","IE00BJLML261.HKD","IE0005OL40V9.USD","IE00BJT1NW94.SGD","LU0122379950.USD","LU2168563687.JPY","LU2237443978.SGD","LU2023251221.USD","LU2461242641.AUD","LU0266013472.USD","GDOC","LU1064131342.USD","LU1868837136.USD","RXL","LU1979441026.SGD","LU0096364046.USD","LU0353189763.USD","LU0353189680.USD","SG9999001176.SGD","LU0345770993.USD","LU0320765992.SGD","LU0316494557.USD","LU0471298694.HKD","LU2361044865.SGD","BK4581","ELIL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673502057","title":"Smaio - Signs Sales Agency Agreement with Depuy Synthes for US Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2673502057","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673502057?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:46","pubTimestamp":1791301593,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S14N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0009355771.USD","LU0058720904.USD","LU0545039389.USD","FHLC","IE00BKVL7J92.USD","IE000WAW04H5.SGD","LU0640476718.USD","LU1228905037.USD","LU2023250330.USD","LU2129689605.HKD","LU0122379950.USD","IXJ","JNJ","LU1121112475.USD","JDOC","IE00BSNM7G36.USD","MEDX","BK4588","LU0345770308.USD","VHT","LU1032466523.USD","LU1894683264.USD","IE00BGHQF631.EUR","IYH","LU1718418525.SGD","LU2417539215.USD","LU2756315318.SGD","PJP","XLV","BK4533","GDOC","RXL","BK4532","LU1629891620.HKD","LU1059921491.USD","IE00B4R5TH58.HKD","LU0985320562.USD","LU2471134879.HKD","BMED","LU1778281490.HKD","LU1430594728.SGD","LU1732800096.USD","TRUH","IE00BBT3K403.USD","IHE","LU1280957306.USD","BK4559","FTXH","LU1674673428.USD","IE000MB6IJN5.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673405782","title":"General Medicine Raises $120 Mln to Build the Healthcare Store","url":"https://stock-news.laohu8.com/highlight/detail?id=2673405782","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673405782?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:33","pubTimestamp":1791300786,"startTime":"0","endTime":"0","summary":"BRIEF-General Medicine Raises $120 Mln To Build The Healthcare StoreOct 6 -GENERAL MEDICINE:GENERAL MEDICINE RAISES $120 MILLION TO BUILD THE HEALTHCARE STOREGENERAL MEDICINE - SERIES B FINANCING LED BY ANDREESSEN HOROWITZ , WITH PARTICIPATION FROM MATRIX, VXI CAPITAL, ELI LILLY AND COMPANYGENERAL MEDICINE - ROUND BRINGS GENERAL MEDICINE'S TOTAL FUNDING TO $152 MILLIONSource text:ID:nPn1fL9XHa","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S1MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0203201768.USD","LU2213496289.HKD","SG9999014914.USD","LU1551013425.SGD","MEDX","LU2552382058.USD","BK4581","LU2106854487.HKD","IE00BK4W5L77.USD","HRTS","LU0238689110.USD","LU1061106388.HKD","LU0203202063.USD","SG9999018857.SGD","LU2271345857.HKD","LU2108987350.USD","LU0882574139.USD","LU0385154629.USD","LU1069344957.HKD","LU1267930730.SGD","IE00BN29S564.USD","LU1232071149.USD","LLYX","OZEM","LU2063271972.USD","LU1127390331.HKD","LU0354030511.USD","LU1064131342.USD","LU2168563687.JPY","LU0640476718.USD","LU2168564149.EUR","LU2237443465.HKD","LU0061475181.USD","LU2265009873.SGD","ELIS","IE00B1XK9C88.USD","LU0471298694.HKD","LU2462591350.SGD","PPH","LU2023250330.USD","LU1868836757.USD","IE00BFTCPJ56.SGD","LU2756315664.SGD","LU0417517546.SGD","LU2237438978.USD","SG9999013999.USD","IE0002141913.USD","LU0786609619.USD","LU2112291526.USD","LU1868837136.USD","LU1814569148.SGD","LU2552382132.HKD","LU1712237335.SGD","FTXH","CANC","IE0004445015.USD","LU2168564222.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","SGXZ51526630.SGD","LU2491050154.USD","VHT","LU0345770993.USD","SGXZ81514606.USD","LU0345770308.USD","LU0689472784.USD","GDOC","IE00B7KXQ091.USD","SG9999015986.USD","LU1548497426.USD","LU2111349929.HKD","IE00BFSS7M15.SGD","LU0225283273.USD","LU0823434740.USD","SG9999018865.SGD","LU2324357040.USD","LU2417539215.USD","RXL","IXJ","LU2602419157.SGD","LU1280957306.USD","ELIL","LU0466842654.USD","SGXZ31699556.SGD","LLYZ","LU1691799644.USD","LU0708995401.HKD","LU2023250504.SGD","LU0256863811.USD","LU0256863902.USD","CURE","LU0672654240.SGD","LU2746668461.USD","SG9999015945.SGD","LU1093756168.USD","LU2089283258.USD","LU2023251221.USD","IE0005OL40V9.USD","LU0964807845.USD","LU0823434583.USD","LU0432979614.USD","LU1720051108.HKD","LU0058720904.USD","LU0943347566.SGD","BK4533","SG9999014906.USD","IE00BJJMRY28.SGD","LU0354030438.USD","LU1323610961.USD","LU2491050071.SGD","BK4588","LU2028103732.USD","SGXZ99366536.SGD","WDNA","LU0158827948.USD","LU0174119429.USD","LU1291159041.SGD","LU0094547139.USD","IE00BFSS8Q28.SGD","LU0471298777.SGD","LU0109394709.USD","LU1988902786.USD","TRUH","LU0198837287.USD","LU1868837300.USD","LU1366192091.USD","LU2461242641.AUD","IE00B1BXHZ80.USD","LU0210536198.USD","LU2361044865.SGD","SGXZ57979304.SGD","BK4599","LU0133085943.USD","FHLC","LU0122379950.USD","LU0114720955.EUR","LU1989771016.USD","IE00B4R5TH58.HKD","LU2360106947.USD","LU2462157665.USD","TMED","LU2237443622.USD","LU2211815571.USD","LU1623119135.USD","LU2089284900.SGD","LU2552382215.SGD","LU2361045086.USD","MHIP","IE00B2B36J28.USD","SG9999015952.SGD","SG9999001176.SGD","LU0353189763.USD","LU0096364046.USD","LU0823416689.USD","LU1979441026.SGD","PJP","IE00BWXC8680.SGD","LU0289739699.SGD","LU0316494557.USD","LU2456880835.USD","IE00BKPKM429.USD","SG9999014898.SGD","BK4534","LU2896262040.SGD","MEDI","IE0004445239.USD","LU0097036916.USD","IE00B775H168.HKD","LU2471134879.HKD","LU2471134952.CNY","LU0456855351.SGD","LU0266013472.USD","IE0009355771.USD","AGNG","LU2237443549.SGD","BK4007","GB00BDT5M118.USD","LU0079474960.USD","LU1917777945.USD","LU0006306889.USD","IE00BJJMRX11.SGD","LU1974910355.USD","LU2237443895.HKD","LU2491049909.HKD","LU1868836591.USD","LU2264538146.SGD","IE0001KFT4U8.USD","LLII","LU0323591593.USD","LU2087625088.SGD","LU0882574055.USD","IE00BK4W5M84.HKD","IHE","LU2471134796.USD","LU0106261372.USD","LU0109391861.USD","LU0320765992.SGD","LU0820562030.AUD","LU0889565916.HKD","LU2089984988.USD","BK4585","LU0320765059.SGD","ILDR","LU1023059063.AUD","LU2357305700.SGD","LU0158827781.USD","LU2750360641.GBP","LU1629891620.HKD","THNR","LU0683600562.USD","LU2746668974.SGD","SG9999001176.USD","LU1551013342.USD","SG9999015978.USD","LU2236285917.USD","LU2756315318.SGD","LU2168564495.EUR","XLV","IE00BJLML261.HKD","SG9999017495.SGD","LU0820561909.HKD","BK4516","JDOC","LLY","LU0820561818.USD","LU1145028129.USD","LU1804176565.USD","IYH","IE00BKDWB100.SGD","LU2237443382.USD","LU0234572021.USD","LU2471134523.USD","SG9999014880.SGD","LU0353189680.USD","LU1035775433.USD","LU1057294990.SGD","LU1720051017.SGD","LU1983299246.USD","LU2361044949.HKD","LU2750360997.AUD","LU2237443978.SGD","IE00B4JS1V06.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","LU1868836914.USD","LU0787776722.HKD","LU2168564065.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673052080","title":"Johnson & Johnson's Innovative Medicines Momentum Offsets MedTech Headwinds, RBC Capital Markets Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2673052080","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673052080?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:21","pubTimestamp":1791300074,"startTime":"0","endTime":"0","summary":"Johnson & Johnson's (JNJ) Innovative Medicines segment acceleration is helping overcome persistent headwinds in its MedTech business, RBC Capital Markets said in a Tuesday note.The investment firm sai","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2430703095.HKD","MEDX","LU0661504455.SGD","LU1121112475.USD","LU0787776722.HKD","LU1057294990.SGD","FHLC","FTXH","GSIB","JNJ","BMED","LU1929549753.HKD","LU1732800096.USD","IXJ","XLV","BK4207","IYH","LU1196500208.SGD","IE00B1BXHZ80.USD","LU2089984988.USD","BK4585","LU1066051498.USD","RXL","LU0289961442.SGD","LU1043141396.HKD","LU2112291526.USD","LU0289739343.SGD","IE00BLSP4452.SGD","LU1032955483.USD","VHT","LU0203345920.USD","LU2133065610.SGD","LU1145028129.USD","LU0128525929.USD","LU0053666078.USD","PJP","IE0001KFT4U8.USD","GDOC","LU0472753341.HKD","MDCO","IE00BZ1G4Q59.USD","IHE","JDOC","IE00BFTCPJ56.SGD","LU0738911758.USD","LU1228905037.USD","LU2471134952.CNY","TRUH","IE000M9KFDE8.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673776052","title":"General Medicine - Series B Financing Led by Andreessen Horowitz (a16z), with Participation from Matrix, Vxi Capital, Eli Lilly and Company","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776052","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776052?lang=en_us&edition=fundamental","pubTime":"2026-10-06 23:20","pubTimestamp":1791300008,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nFWN45S1MX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0006306889.USD","SG9999018865.SGD","LU0471298777.SGD","LU1974910355.USD","LU0058720904.USD","LU1979441026.SGD","LU2168564065.EUR","LU2023251221.USD","LU1064131342.USD","TRUH","LU0820562030.AUD","JDOC","LU0094547139.USD","LU1868836757.USD","IE00B4JS1V06.HKD","LU2168563687.JPY","LU1983299246.USD","LU2361045086.USD","SGXZ81514606.USD","LU2168564495.EUR","LU2265009873.SGD","LU1720051108.HKD","CURE","LU0225283273.USD","LU0787776722.HKD","SG9999014914.USD","LU1712237335.SGD","SG9999014880.SGD","LU2108987350.USD","LU0133085943.USD","LU1917777945.USD","MHIP","LU2462157665.USD","LU0266013472.USD","GB00BDT5M118.USD","LLYZ","LU1145028129.USD","LU2112291526.USD","LU2357305700.SGD","LU0238689110.USD","LU1280957306.USD","SGXZ31699556.SGD","LU2089284900.SGD","LU2237443978.SGD","IE00BJT1NW94.SGD","LU1720051017.SGD","LU2063271972.USD","LU2896262040.SGD","LU2491050154.USD","SGXZ99366536.SGD","BK4516","LU0122379950.USD","LU0316494557.USD","ELIS","TMED","SG9999017495.SGD","IE0004445239.USD","LU0096364046.USD","LU2602419157.SGD","LU2360106947.USD","LU2106854487.HKD","LU2462591350.SGD","IE00BFSS8Q28.SGD","LU2471134952.CNY","LU2750360641.GBP","LU0345770993.USD","SG9999015978.USD","IE00BWXC8680.SGD","IE00B775H168.HKD","LU2264538146.SGD","LU0109394709.USD","LU2237443622.USD","IE00B1BXHZ80.USD","IE00B2B36J28.USD","LU1804176565.USD","LU2087625088.SGD","LU2236285917.USD","LU0354030511.USD","LU1323610961.USD","LU2211815571.USD","WDNA","SG9999018857.SGD","VHT","LU1988902786.USD","SG9999014898.SGD","IE00B1XK9C88.USD","LU0256863811.USD","LU1366192091.USD","PPH","FHLC","LLII","ELIL","LU2089984988.USD","SG9999015952.SGD","LU2213496289.HKD","SGXZ57979304.SGD","IE00BJJMRY28.SGD","LU0683600562.USD","IE00BJJMRX11.SGD","LU0820561909.HKD","IE00BFTCPJ56.SGD","SGXZ51526630.SGD","LU0158827948.USD","LU2168564222.USD","GDOC","IE0009355771.USD","LU0345770308.USD","LU0289739699.SGD","LU0466842654.USD","LU2237443382.USD","LU0114720955.EUR","LU0708995401.HKD","LU0882574055.USD","LU0210536198.USD","LU0882574139.USD","MEDI","LU0943347566.SGD","LU1868837300.USD","IE0001KFT4U8.USD","LU0256863902.USD","LU2471134796.USD","LU0061475181.USD","LU2028103732.USD","BK4585","LU1057294990.SGD","LU1868836591.USD","LU2471134523.USD","IE00BKPKM429.USD","LU1069344957.HKD","LU1127390331.HKD","LU1814569148.SGD","LU0079474960.USD","LU1267930730.SGD","LU2756315664.SGD","MEDX","IXJ","BK4588","LU0203202063.USD","LU0432979614.USD","LU1061106388.HKD","LU2491050071.SGD","LU0203201768.USD","BK4533","LU0353189680.USD","LU1023059063.AUD","LU1232071149.USD","IE00BK4W5M84.HKD","LU2456880835.USD","LU1093756325.SGD","LU0417517546.SGD","IE00B7KXQ091.USD","LU2417539215.USD","IE00BN29S564.USD","LU2023250330.USD","LU1551013342.USD","LU1868836914.USD","IE00BFSS7M15.SGD","ILDR","LU0823416689.USD","LU2089283258.USD","THNR","IE00BK4W5L77.USD","LU0964807845.USD","LU2111349929.HKD","LU0471298694.HKD","HRTS","LU0786609619.USD","LU1868837136.USD","XLV","LU1035775433.USD","LU0234572021.USD","LU0889565916.HKD","FTXH","LU0823434583.USD","LU0820561818.USD","LU1093756168.USD","IE00BJJMRZ35.SGD","LU2552382132.HKD","SG9999015945.SGD","LU2023250504.SGD","LU2324357040.USD","LU1551013425.SGD","BK4534","LU0672654240.SGD","LU1629891620.HKD","LU2746668974.SGD","LU2750360997.AUD","IE0004445015.USD","CANC","IE00B4R5TH58.HKD","IE00BKDWB100.SGD","LU0320765992.SGD","LU1548497426.USD","LU1691799644.USD","LU2168564149.EUR","BK4599","BK4581","LU0320765059.SGD","RXL","SG9999001176.SGD","IYH","LU0354030438.USD","LU2237443549.SGD","IE0002141913.USD","AGNG","LU0640476718.USD","LU2271345857.HKD","LU0174119429.USD","LU0158827781.USD","LU2468319806.SGD","LU0385154629.USD","LU2756315318.SGD","LU2361044865.SGD","LU0456855351.SGD","LU0198837287.USD","SG9999015986.USD","IHE","LU2746668461.USD","PJP","LU2552382058.USD","LU1291159041.SGD","SG9999001176.USD","LU1623119135.USD","LU2491049909.HKD","LU2552382215.SGD","LU0689472784.USD","LU2237443465.HKD","SG9999013999.USD","IE00BJLML261.HKD","LLYX","LU2471134879.HKD","LU1989771016.USD","IE0005OL40V9.USD","LU0097036916.USD","LU2361044949.HKD","LU2237438978.USD","LLY","LU0106261372.USD","BK4007","LU0109391861.USD","OZEM","LU0353189763.USD","LU0323591593.USD","LU2461242641.AUD","LU2237443895.HKD","LU0823434740.USD","SG9999014906.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673300037","title":"European Shares Gain as Genmab Jumps, Bond Yields Retreat","url":"https://stock-news.laohu8.com/highlight/detail?id=2673300037","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673300037?lang=en_us&edition=fundamental","pubTime":"2026-10-06 16:51","pubTimestamp":1791276686,"startTime":"0","endTime":"0","summary":"European shares gain as Genmab jumps, bond yields retreatOct 6 (Reuters)-European shares rose towards one-week highs on Tuesday, buoyed by gains in healthcare stocks after Genmab's upbeat drug-trial r","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL4N45S0H3:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","LU1162221912.USD","SG9999015945.SGD","LU0198837287.USD","LU1718418525.SGD","LU1929549753.HKD","LU2129689431.USD","LU0203347892.USD","LU0661504455.SGD","ABBV","LU2237443382.USD","LU0861579265.USD","PPH","RXL","SG9999001440.SGD","IE0002141913.USD","LU2237443895.HKD","LU1551013342.USD","JDOC","LU0965508806.USD","LU0738911758.USD","LU1236620750.USD","LU2089984988.USD","LU0114720955.EUR","LU1989771016.USD","LU0203345920.USD","XLV","FTXH","BK4534","PJP","GLAM","LU0234570918.USD","LU1585245621.USD","IE00B2B36J28.USD","IE00B3PB1722.GBP","VHT","LU0472753341.HKD","LU1061106388.HKD","AGNG","TRUH","LU2133065610.SGD","IYH","LU1670627923.USD","LU1496350171.SGD","LU1057294990.SGD","IE00BGHQF631.EUR","MEDX","FHLC","LU1732799900.SGD","IXJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673079034","title":"LIVE Markets-a Health Boost for the STOXX","url":"https://stock-news.laohu8.com/highlight/detail?id=2673079034","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673079034?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:54","pubTimestamp":1791273288,"startTime":"0","endTime":"0","summary":"LIVE MARKETS-A health boost for the STOXXAdds blog postSTOXX 600 up 0.8%Healthcare stocks lead gains, boosted by 8% jump in Genmab sharesWall St futures steadyWelcome to the home for real-time coverag","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL6N45S0G7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1162221912.USD","LU0122379950.USD","PPH","LU0310799852.SGD","LU1236620750.USD","LU1551013425.SGD","JDOC","LU0395794307.EUR","LU0795875086.SGD","LU0256863811.USD","TRUH","LU2129689514.USD","BK4139","BK4533","LU0661504455.SGD","LU0211327993.USD","MEDX","RXL","LU2089984988.USD","GLAM","LU0029864427.USD","LU0726765562.USD","ABBV","LU0128525929.USD","PJP","LU0289739699.SGD","SG9999001440.SGD","IE00BVYPNV92.GBP","IE000WAW04H5.SGD","FTXH","XLV","LU0320765646.SGD","IYH","LU2357627491.SGD","AGNG","FHLC","LU0203345920.USD","SG9999015952.SGD","VHT","LU1720051017.SGD","BK4534","IE00B3PB1722.GBP","LU1093756325.SGD","LU1839511570.USD","IE0009355771.USD","BK4550","LU2468319806.SGD","IXJ","LU0949170772.SGD","LU2433249047.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673103450","title":"Genmab at 3-Year High After Blood Cancer Drug Combination Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2673103450","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673103450?lang=en_us&edition=fundamental","pubTime":"2026-10-06 15:18","pubTimestamp":1791271123,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab at 3-year high after blood cancer drug combination study results** Shares in GenmabGMAB.COrise around 8%to their highest in three years, hitting top of STOXX 600.STOXXindex** Genmab and Ab","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nL8N45S0BH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","MEDX","LU2357305700.SGD","LU1934455863.HKD","LU1244550494.USD","FHLC","FTXH","IE00B19Z3581.USD","LU1929549753.HKD","LU1732800096.USD","IXJ","XLV","IE00B42XCP33.USD","LU0456855351.SGD","LU0795875086.SGD","LU1732799900.SGD","IYH","LU1003077747.HKD","LU0708994859.HKD","LU0912757837.SGD","RXL","VHT","LU0942090050.USD","LU0203345920.USD","GLAM","IE0000B7K699.USD","LU0417517546.SGD","LU1037948541.HKD","LU2237443622.USD","IE000MB6IJN5.SGD","SG9999003800.SGD","IE00BDGV0183.EUR","LU0868494617.USD","PJP","ABBV","LU2129689514.USD","IE00BSNM7G36.USD","AGNG","LU0472753341.HKD","SG9999001440.SGD","BK4139","LU0859254822.USD","BK4550","LU1989772923.USD","JDOC","LU0211328371.USD","TRUH","LU0882574055.USD","LU0256863811.USD","PPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673080374","title":"Tech Coast Angels Reports Profitable Atraverse Medical Exit After Johnson & Johnson Acquisition, Citing 70%+ IRR","url":"https://stock-news.laohu8.com/highlight/detail?id=2673080374","media":"Reuters","labels":["shareholding","corporation","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673080374?lang=en_us&edition=fundamental","pubTime":"2026-10-06 08:05","pubTimestamp":1791245145,"startTime":"0","endTime":"0","summary":"Tech Coast Angels reports profitable Atraverse Medical exit after Johnson & Johnson acquisition, citing 70%+ IRRTech Coast Angels reported a profitable exit from Atraverse Medical following its acquis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261006:nNDL17Q5Wq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,corporation,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1228905037.USD","BK4585","IHE","LU1732800096.USD","LU1914381329.SGD","JDOC","LU0787776722.HKD","MEDX","LU1066051225.USD","LU0124676726.USD","BK4532","LU0912757837.SGD","LU0466842654.USD","LU1894683348.USD","RXL","LU1059921491.USD","LU2505996681.GBP","VHT","IXJ","LU0985320562.USD","GDOC","SG9999002232.USD","FHLC","FTXH","TRUH","LU0820562030.AUD","LU1221951129.SGD","BMED","LU2430703095.HKD","LU2236285917.USD","LU2471134796.USD","LU0345770308.USD","IE000BZT7R73.USD","LU1935042991.SGD","LU2430703178.SGD","JNJ","LU0882574055.USD","IE00BFXG1179.USD","LU1244550494.USD","LU2417539215.USD","IYH","LU2403377893.USD","LU0345769128.USD","XLV","LU2750360641.GBP","IE000M9KFDE8.USD","PJP","LU0122379950.USD","LU1291159041.SGD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673829530","title":"L'Oreal Explores Unloading Chemical-Related Liabilities, WSJ Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2673829530","media":"Reuters","labels":["event","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673829530?lang=en_us&edition=fundamental","pubTime":"2026-10-06 05:36","pubTimestamp":1791236175,"startTime":"0","endTime":"0","summary":"UPDATE 2-L'Oreal explores unloading chemical-related liabilities, WSJ reportsOct 5 (Reuters)-L'OrealOREP.PAhas engaged restructuring advisers to explore options for rising US legal liabilities linked ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nL6N45R14J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BMED","LU0545039389.USD","LU1023059063.AUD","IHE","LU2023250330.USD","LU0787776722.HKD","SGXZ57979304.SGD","GDOC","IE00BSNM7G36.USD","LU0964807845.USD","SG9999002224.SGD","LU0203347892.USD","IE00B3PB1722.GBP","LU1228905037.USD","LU1074936037.SGD","LU1551013342.USD","HONG","IYH","LU0072461881.USD","IE00B19Z3B42.SGD","FTXH","LU2112291526.USD","FHLC","LU0912757837.SGD","LU0820561818.USD","LU2505996509.AUD","LU0545562505.USD","LU0640476718.USD","PJP","JDOC","IE00BFXG1179.USD","JNJ","XLV","LU1032466523.USD","LU2430703178.SGD","HON","TRUH","RXL","LU0289961442.SGD","LU2430703251.USD","LU0289739343.SGD","BK4504","VHT","IXJ","LU0949170772.SGD","IE00BKVL7J92.USD","LU0889566641.SGD","LU0689626769.HKD","LU2403377893.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084910","title":"Medtronic PLC Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084910","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084910?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:38","pubTimestamp":1791232680,"startTime":"0","endTime":"0","summary":"DJ Medtronic PLC Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Medtronic PLC  advanced 1.84% to $87.97 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.Medtronic PLC closed 17.27% short of its 52-week high of $106.33, which the company reached on November 26th.The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Danaher Corp.  rose 3.34% to $221.21, and Abbott Laboratories  rose 2.67% to $100.10.Trading volume  eclipsed its 50-day average volume of 10.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","IE0004445239.USD","LU0345770308.USD","RXL","VHT","LU1674673691.USD","TMED","IHI","LU1718418525.SGD","IXJ","TRUH","MEDX","ABT","LU0314106906.USD","LU1145028129.USD","LU2125909593.SGD","IYH","LU1061106388.HKD","FHLC","IE00B3PB1722.GBP","MDT","DHR","FMED","LU2063271972.USD","LU1280957306.USD","SG9999013999.USD","IHE","GDOC","FTXH","LU0122379950.USD","LU1923622614.USD","XLV","LU1989763427.SGD","LU1003077747.HKD","LU0211326839.USD","LU0070302665.USD","BMED","SG9999001176.SGD","JNJ","SGXZ57979304.SGD","JDOC","LU1778281490.HKD","LU1983299246.USD","SG9999001176.USD","IE00BKVL7J92.USD","LU2430703095.HKD","LU0006306889.USD","LU1066051225.USD","LU0943347566.SGD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084323","title":"AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084323","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084323?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:31","pubTimestamp":1791232260,"startTime":"0","endTime":"0","summary":"DJ AbbVie Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of AbbVie Inc.  advanced 1.12% to $265.76 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.66% to 7,773.95 and the Dow Jones Industrial Average  rising 0.18% to 51,267.90.This was the stock's second consecutive day of gains.AbbVie Inc. closed 1.35% short of its 52-week high of $269.39, which the company achieved on September 23rd.The stock outperformed some of its competitors Monday, as Johnson & Johnson  fell 1.21% to $252.93, Pfizer Inc.  fell 1.40% to $27.41, and Amgen Inc.  fell 0.01% to $402.98.Trading volume  eclipsed its 50-day average volume of 4.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled October 5, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1236620834.HKD","LU2347655156.SGD","LU0124676726.USD","LU0211327993.USD","LU0965509010.AUD","LU2237443382.USD","JDOC","LU0795875086.SGD","PPH","FHLC","LU1267930490.SGD","LU0256863811.USD","LU1732799900.SGD","FTXH","LU2089283258.USD","LU0861579265.USD","LU1291159041.SGD","LU2129689605.HKD","LU0965508806.USD","BK4581","IE000F7OJYX1.SGD","LU0661504455.SGD","LU1430594728.SGD","LU0726765562.USD","IE00B3PB1722.GBP","IE00B19Z3581.USD","LU2087621335.USD","LU0395794307.EUR","IE0000B7K699.USD","LU2023251221.USD","IE00BN8TJ469.HKD","LU1003077747.HKD","LU1244550494.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU2237443549.SGD","IE0002141913.USD","LU0820561909.HKD","LU2129689514.USD","LU0965509101.SGD","IE0009355771.USD","LU1839511570.USD","LU1093756168.USD","IE00BSNM7G36.USD","BK4588","LU0859254822.USD","LU0320765646.SGD","LU1585245621.USD","LU0122379950.USD","LU0689626769.HKD","LU2357627491.SGD","BK4533","IE00BJJMRZ35.SGD","LU0029864427.USD","LU2125909247.SGD","LU0198837287.USD","LU1057294990.SGD","LU1267930573.SGD","ABBV","IE00BFTCPJ56.SGD","LU0708994859.HKD","AGNG","LU0170899867.USD","LU0289739343.SGD","RXL","SG9999015986.USD","LU0310800379.SGD","LU1934455277.USD","LU1929549753.HKD","LU0472753341.HKD","LU2433249047.HKD","LU2112291526.USD","IE00BLSP4452.SGD","LU1732800096.USD","IE00B42XCP33.USD","LU2237443978.SGD","LU0985320562.USD","LU0882574055.USD","LU2089984988.USD","GLAM","BK4550","IE00B2B36J28.USD","LU1037948541.HKD","LU0234572021.USD","IE0002270589.USD","LU1670627923.USD","LU0868494617.USD","LU0942090050.USD","LU1023059063.AUD","LU1923622614.USD","LU1162221912.USD","LU0545039389.USD","SG9999001440.SGD","LU1989772840.SGD","LU0738911758.USD","LU1093756325.SGD","LU1720051108.HKD","MEDX","LU2237443895.HKD","LU1989772923.USD","LU0234570918.USD","LU0912757837.SGD","LU0256863902.USD","LU1551013425.SGD","LU1670628061.USD","PJP","LU1718418525.SGD","LU2133065610.SGD","IE000WAW04H5.SGD","LU0820561818.USD","LU0310799852.SGD","LU0965509283.SGD","LU0511384066.AUD","IE00BVYPNW00.USD","LU1061106388.HKD","LU0417517546.SGD","LU2237443622.USD","LU2237443465.HKD","LU1720051017.SGD","LU0128525929.USD","SG9999015952.SGD","XLV","LU0456855351.SGD","VHT","BK4534","IE000BZT7R73.USD","LU0949170772.SGD","LU1496350502.SGD","LU1934455863.HKD","LU1548497426.USD","IE00BGHQF631.EUR","LU0158827948.USD","LU0289739699.SGD","LU0211328371.USD","LU0943347566.SGD","LU1244550577.SGD","LU1551013342.USD","IE000SO60NU8.SGD","LU0289961442.SGD","LU0203347892.USD","IE00BLSP4239.USD","IE00BBT3K403.USD","LU0689472784.USD","SG9999015945.SGD","LU1983299246.USD","LU2468319806.SGD","LU0823416689.USD","LU1244550221.USD","BK4585","LU2357305700.SGD","IE00BDGV0183.EUR","LU0069063385.USD","LU1989771016.USD","SG9999011175.SGD","LU0203345920.USD","LU0057025933.USD","LU1934455194.USD","LU2125909593.SGD","BK4566","IE000MB6IJN5.SGD","IE00B4R5TH58.HKD","IYH","SG9999003800.SGD","LU0432979614.USD","LU0868494708.USD","LU1496350171.SGD","LU1037948897.HKD","LU0795875169.SGD","LU2347655073.USD","LU1074936037.SGD","IE00BJT1NW94.SGD","LU0058720904.USD","IE00BVYPNV92.GBP","LU1236620750.USD","BK4559","TRUH","LU0098860793.USD","LU2089284900.SGD","BK4139","SG9999015978.USD","IE0004445239.USD","IXJ","LU2129689431.USD","LU0553294199.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673084883","title":"Bristol-Myers Squibb Co: Prelim Total Acquired Iprd and Licensing Income $1,536 Mln for Three Months Ended September 30, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2673084883","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673084883?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:21","pubTimestamp":1791231689,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nFWN45R1EE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2133065610.SGD","LU0096364046.USD","LU1032466523.USD","LU0306806265.USD","LU1718418525.SGD","BMY","LU2596442595.SGD","LU2125154778.USD","LU1670710588.SGD","IE0009355771.USD","LU0456855351.SGD","LU1236620834.HKD","LU1261432733.SGD","BK4007","LU0061475181.USD","LU1323610961.USD","LU0321505868.SGD","LU2360032135.SGD","LU1868836591.USD","IHE","LU1868836914.USD","IE00BJJMRZ35.SGD","LU1883839398.USD","LU0321505439.SGD","BK4585","BK4532","LU1571399168.USD","BK4534","LU1291159041.SGD","LU1670711040.USD","LU0868494617.USD","LU1670710661.SGD","LU1868836757.USD","LU0985481810.HKD","BK4581","IE00B2B36J28.USD","LU1983299246.USD","LU1868837136.USD","LU2242652126.USD","LU1093756325.SGD","BK4559","FTXH","IE00BFTCPJ56.SGD","LU0225284248.USD","LU0237698245.USD","LU1670711123.USD","BK4588","LU0882574055.USD","LU1093756168.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673081209","title":"AbbVie Cuts Q3 Adjusted Diluted EPS Outlook to $3.73-$3.77 After $216 Million Acquired Ipr&d, Milestones Expense","url":"https://stock-news.laohu8.com/highlight/detail?id=2673081209","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673081209?lang=en_us&edition=fundamental","pubTime":"2026-10-06 04:09","pubTimestamp":1791230948,"startTime":"0","endTime":"0","summary":"AbbVie cuts Q3 adjusted diluted EPS outlook to $3.73-$3.77 after $216 million acquired IPR&D, milestones expenseAbbVie cut Q3 2026 adjusted diluted EPS guidance to USD 3.73–3.77 from USD 3.84–3.88, re","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261005:nNDLbW9K2t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","SG9999015978.USD","BK4550","GLAM","IE000SO60NU8.SGD","LU1236620750.USD","FHLC","IYH","LU0122379950.USD","LU0943347566.SGD","LU0553294199.USD","LU1934455863.HKD","LU0320765646.SGD","BK4588","FTXH","LU0170899867.USD","BK4534","LU1732799900.SGD","LU2023251221.USD","IE00B3PB1722.GBP","LU1037948541.HKD","MEDX","LU1720051108.HKD","LU1585245621.USD","LU0158827948.USD","LU1430594728.SGD","LU1023059063.AUD","XLV","ABBV","LU1162221912.USD","LU0661504455.SGD","LU1236620834.HKD","LU1267930573.SGD","IE0002141913.USD","IE0004445239.USD","JDOC","IXJ","TRUH","IE000BZT7R73.USD","LU0203345920.USD","PPH","RXL","IE00BGHQF631.EUR","PJP","VHT","LU2237443978.SGD","AGNG","IE00BDGV0183.EUR","LU0234570918.USD","LU0128525929.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":17,"pageCount":5,"totalSize":322,"code":"91000000","status":"200"}]}}